Clinical Trial News

AstraZeneca's breast cancer drug, Etcamah, failed to meet its primary goal in a late-stage trial, showing only a numerical improvement when combined with palboc

A small clinical trial suggests that modified bone-seeking marrow cells could have regenerative potential for rebuilding bones, offering a new approach to treat

A blood cancer patient remains alive eight years after participating in a groundbreaking trial, with approximately 70% of trial participants still alive six yea

A U.S. study is testing psilocybin as a treatment for cancer side effects. Researchers warn that psilocybin can act as an "amplifier," potentially increasing st

The heart drug Pelacarsen, developed by Novartis, failed in a large clinical trial, surprising both the company and cardiologists who had hoped it would be a si

An international clinical trial is set to test an experimental Alzheimer's drug on healthy middle-aged individuals without symptoms, aiming to prevent the devel

A small trial has shown that a modified virus can be engineered inside the body to instruct the immune system to eliminate disease-causing cells, offering a pot

A world-first clinical trial has demonstrated that a common cholesterol-lowering medication significantly reduces the risk of major cardiovascular events in old

Moderna's mRNA melanoma vaccine, intismeran, has shown promise in early trials by slowing the recurrence of skin cancer in patients. This development suggests t

A new clinical trial has allowed approximately 80 percent of bowel cancer patients to avoid major surgery, described as a 'life-changing' outcome.

Jack Cope, who suffers from hereditary angioedema, has seen significant improvement in his condition after participating in a new clinical trial at Addenbrooke'

A personalized cancer vaccine developed by Moderna and Merck has shown success in a final-stage melanoma trial. Researchers are hopeful this approach could be u

Moderna and Merck announced that a new personalized mRNA vaccine significantly reduced the risk of melanoma recurrence and spread in a late-stage trial, marking

Merck and Moderna announced that their personalized mRNA vaccine successfully prevented melanoma recurrence in high-risk patients during a late-stage trial, tho

Moderna and Merck's personalized mRNA cancer vaccine has met its primary goals in a Phase 3 trial for high-risk melanoma, marking a significant breakthrough and

Moderna's stock surged after the company and Merck announced "landmark moment" study results for their melanoma vaccine trial, showing significant progress in t

Moderna's shares surged by 95% following the successful final-stage trial of its mRNA-based cancer drug, marking a significant milestone as the first successful

Moderna shares soared nearly 100% after its mRNA vaccine, developed with Merck, showed success in a large trial for skin cancer. Interim results indicated the t

Victoria Gray, the first person to receive an experimental CRISPR treatment for sickle cell disease in 2019, is now living a life free from severe pain and tran

Neena Nizar, through her determination, has become the first patient in a clinical trial for a rare disease that affects only 30 people globally.

A patient has died during a gene editing trial conducted by a biotech company in China.

A new study indicates that a cannabis-derived drug has been shown to reduce nightmares in a clinical trial.

Harper Tanton, a girl from Nova Scotia with the ultra-rare CTNNB1 syndrome, will be one of the first children globally to participate in a clinical trial for a

A major trial has found that liquid fluoride can effectively prevent cavities without drilling, as children who received direct application experienced less fur